NCT07156175View on ClinicalTrials.gov

A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

April 8, 2027

Study Completion Date

May 6, 2027

Conditions

Microscopic Colitis

Interventions

DRUG

SAR444336

Pharmaceutical form:Solution for injection -Route of administration:Subcutaneous

DRUG

Placebo

Pharmaceutical form:Solution for injection -Route of administration:Subcutaneous

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT07156175 - A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission | Biotech Hunter | Biotech Hunter